Clinical trials
Phase 1/2 Leukemia, Myeloid, Chronic-Phase trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2020 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 6 |
| OHSU Knight Cancer Institute | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Bristol-Myers Squibb | 1 |
| Cancer Treatment Centers of America | 1 |
| Children's Oncology Group | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Milton S. Hershey Medical Center | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Chronic-Phase | 23 |
| Leukemia | 16 |
| Leukemia, Myeloid, Accelerated Phase | 16 |
| Blast Crisis | 12 |
| Leukemia, Myeloid, Acute | 11 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Lymphoma, Follicular | 9 |
| Lymphoma, Large B-Cell, Diffuse | 9 |
| Lymphoma, Mantle-Cell | 9 |
| Lymphoma, Non-Hodgkin | 9 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.